2012
DOI: 10.1124/pr.110.004051
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
73
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 108 publications
(74 citation statements)
references
References 272 publications
(311 reference statements)
0
73
0
Order By: Relevance
“…We previously showed that PI3Kd in synoviocytes is engaged downstream of the PDGF-R and regulates growth and survival via Akt activation (12). PI3Kd is also important for leukocyte chemotaxis in physiological and pathologic responses such as inflammation and hematologic malignancy (8,10,36,37). PI3Kd activity has been linked to cancer cell migration in breast cancer, neuroblastoma, and glioblastoma, and, aberrant expression of PI3Kd in tumors might contribute to the malignant properties of cancer cells (37)(38)(39).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We previously showed that PI3Kd in synoviocytes is engaged downstream of the PDGF-R and regulates growth and survival via Akt activation (12). PI3Kd is also important for leukocyte chemotaxis in physiological and pathologic responses such as inflammation and hematologic malignancy (8,10,36,37). PI3Kd activity has been linked to cancer cell migration in breast cancer, neuroblastoma, and glioblastoma, and, aberrant expression of PI3Kd in tumors might contribute to the malignant properties of cancer cells (37)(38)(39).…”
Section: Discussionmentioning
confidence: 99%
“…PI3Ks control overlapping and nonredundant functions ranging from cell growth and proliferation to migration and cytokine expression (6,7). Perturbing this signaling cascade is implicated in inflammatory and autoimmune disorders as well as cancer (8)(9)(10)(11).…”
mentioning
confidence: 99%
“…Lack of PTEN protein was confirmed in all relevant cell lines (RPMI8402 expresses a mutant non-functioning allele) (Fig 1). An initial panel of compounds, including an inhibitor of all class 1 PI3Ks (PIK90) and selective inhibitors of p110 (TGX221), p110 (IC87114) and p110 (AS604850) (Foster et al, 2012), was used to investigate the effects of blocking PI3K activity on cell proliferation. Optimal concentrations that fully inhibit the relevant isoform(s) were used based on the literature and previous experiments (Foukas et al, 2010;Weigelt & Downward, 2012).…”
mentioning
confidence: 99%
“…There is currently an intense focus by pharmaceutical companies to develop PI3K inhibitors as therapy for cancer, cardiovascular, respiratory, autoimmune and inflammatory diseases [14].…”
Section: Discussionmentioning
confidence: 99%